banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ2000 Clove essential oil nanoliposomes
X26-05-ZQ2001 Erythrocyte membrane lipid-coated harringtonine liposomes
X26-05-ZQ2002 Cell membrane-encapsulated docetaxel long-circulating liposomes
X26-05-ZQ2003 HMME-containing liposomes
X26-05-ZQ2004 Erythrocyte membrane-coated triptolide-celastrol biomimetic co-loaded liposomes
X26-05-ZQ2005 Antibody-conjugated multifunctional lipid shell microbubbles
X26-05-ZQ2006 Doxorubicin-modified nanostructured lipid carriers (DOX-NLC)
X26-05-ZQ2007 Erythrocyte phosphatidylethanolamine liposomes
X26-05-ZQ2008 Leukocyte membrane-modified paclitaxel-targeted sustained-release liposomes
X26-05-ZQ2009 PTX-modified liposomes
X26-05-ZQ2010 Graphene-modified liposomes
X26-05-ZQ2011 PEG-modified liposomes fused with pancreatic cancer cell PANC-1 cell membrane (M-PEG-LIP)
X26-05-ZQ2012 siRNA-loaded cationic liposomes
X26-05-ZQ2013 Telomerase antisense oligonucleotide-loaded cationic liposomes
X26-05-ZQ2014 Borneol-modified tanshinone IIA cationic liposomes (TA-BCLPs)
X26-05-ZQ2015 Apolipoprotein E-conjugated liposomes
X26-05-ZQ2016 Sucrose fatty acid ester-type cationic liposomes
X26-05-ZQ2017 Antisense oligonucleotide/span-modified cationic liposomes
X26-05-ZQ2018 N-Trimethyl chitosan (TMC)-coated cationic liposomes
X26-05-ZQ2019 DDCTMA cationic liposomes
X26-05-ZQ2020 β-Cyclodextrin liposomes
X26-05-ZQ2021 Cationic liposome-conjugated apolipoprotein E
X26-05-ZQ2022 DOPE-embedded cationic liposomes
X26-05-ZQ2023 Antibody-modified liposomes
X26-05-ZQ2024 Honokiol and siRNA co-delivery cationic liposomes
X26-05-ZQ2025 Cholesterol-type cationic liposomes
X26-05-ZQ2026 Platelet membrane glycoprotein liposomes
X26-05-ZQ2027 ApoE-modified cationic liposomes
X26-05-ZQ2028 Zoledronic acid cationic liposomes
X26-05-ZQ2029 Gatifloxacin cationic liposomes
X26-05-ZQ2030 Betaxolol hydrochloride cationic liposomes
X26-05-ZQ2031 GFP plasmid DNA/cationic liposome complexes
X26-05-ZQ2032 Antisense oligonucleotide cationic liposomes
X26-05-ZQ2033 MAL functional group-modified liposomes
X26-05-ZQ2034 Gentamicin cationic liposomes
X26-05-ZQ2035 Paeonol cationic liposomes
X26-05-ZQ2036 Vitamin-modified liposomes
X26-05-ZQ2037 Trastuzumab-modified toxin protein-encapsulated PEGylated immunoliposomes
X26-05-ZQ2038 Liposome-modified gold nanoparticles
X26-05-ZQ2039 Hsp70-HSV-2gD fusion protein vaccine cationic liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.